PL3459543T3 - Związek karbaminianowy do zapobiegania lub leczenia fibromialgii - Google Patents
Związek karbaminianowy do zapobiegania lub leczenia fibromialgiiInfo
- Publication number
- PL3459543T3 PL3459543T3 PL17799675.8T PL17799675T PL3459543T3 PL 3459543 T3 PL3459543 T3 PL 3459543T3 PL 17799675 T PL17799675 T PL 17799675T PL 3459543 T3 PL3459543 T3 PL 3459543T3
- Authority
- PL
- Poland
- Prior art keywords
- preventing
- carbamate compound
- treating fibromyalgia
- fibromyalgia
- treating
- Prior art date
Links
- -1 Carbamate compound Chemical class 0.000 title 1
- 208000001640 Fibromyalgia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061392 | 2016-05-19 | ||
| PCT/KR2017/005173 WO2017200318A1 (ko) | 2016-05-19 | 2017-05-18 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3459543T3 true PL3459543T3 (pl) | 2023-04-11 |
Family
ID=60325216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17799675.8T PL3459543T3 (pl) | 2016-05-19 | 2017-05-18 | Związek karbaminianowy do zapobiegania lub leczenia fibromialgii |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10849882B2 (enExample) |
| EP (1) | EP3459543B1 (enExample) |
| JP (1) | JP7071287B2 (enExample) |
| KR (1) | KR102489052B1 (enExample) |
| CN (1) | CN109475529B (enExample) |
| AU (1) | AU2017265839B2 (enExample) |
| BR (1) | BR112018073553A2 (enExample) |
| CA (1) | CA3024286A1 (enExample) |
| DK (1) | DK3459543T3 (enExample) |
| ES (1) | ES2935596T3 (enExample) |
| MX (1) | MX394245B (enExample) |
| PL (1) | PL3459543T3 (enExample) |
| RU (1) | RU2753525C2 (enExample) |
| WO (1) | WO2017200318A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11033531B2 (en) * | 2016-12-14 | 2021-06-15 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome |
| US20200352907A1 (en) | 2017-11-14 | 2020-11-12 | Sk Biopharmaceuticals Co., Ltd. | Use Of Carbamate Compound For Preventing, Alleviating Or Treating Absence Seizure Or Epilepsy Showing Absence Seizure |
| ES2973111T3 (es) * | 2017-11-14 | 2024-06-18 | Sk Biopharmaceuticals Co Ltd | Uso de un compuesto de carbamato para prevenir o tratar enfermedades asociadas con el aumento de la corriente tardía de sodio |
| US11666554B2 (en) * | 2017-11-14 | 2023-06-06 | Sk Biopharmaceuticals Co., Ltd. | Use of a carbamate compound to prevent, alleviate or treat visceralgia or pain arising from visceral disease |
| WO2020080866A1 (ko) * | 2018-10-19 | 2020-04-23 | 에스케이바이오팜 주식회사 | 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도 |
| CA3157788A1 (en) * | 2019-11-22 | 2021-05-27 | Ji Hye Lee | Oral pharmaceutical composition comprising carbamate compound and preparation method therefor |
| IT202300007314A1 (it) | 2023-04-14 | 2024-10-14 | Soal Pharma Srl | Integratore alimentare per il trattamento della fibromialgia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) * | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| ES2278035T3 (es) * | 2001-07-16 | 2007-08-01 | Ortho-Mcneil Pharmaceutical, Inc. | Compuestos de carbamato destinados a ser utilizados en la prevencion o el tratamiento del dolor neuropatico y del dolor asociado a las cefaleas agrupadas y por migrañas. |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| AU2009348523B2 (en) * | 2009-06-22 | 2015-02-26 | Sk Biopharmaceuticals Co., Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| ES2743153T3 (es) * | 2009-11-06 | 2020-02-18 | Sk Biopharmaceuticals Co Ltd | Métodos para tratar el síndrome de fibromialgia |
-
2017
- 2017-05-16 KR KR1020170060714A patent/KR102489052B1/ko active Active
- 2017-05-18 CA CA3024286A patent/CA3024286A1/en active Pending
- 2017-05-18 US US16/302,858 patent/US10849882B2/en active Active
- 2017-05-18 PL PL17799675.8T patent/PL3459543T3/pl unknown
- 2017-05-18 ES ES17799675T patent/ES2935596T3/es active Active
- 2017-05-18 RU RU2018144785A patent/RU2753525C2/ru active
- 2017-05-18 BR BR112018073553-1A patent/BR112018073553A2/pt not_active Application Discontinuation
- 2017-05-18 EP EP17799675.8A patent/EP3459543B1/en active Active
- 2017-05-18 CN CN201780030906.XA patent/CN109475529B/zh active Active
- 2017-05-18 MX MX2018014080A patent/MX394245B/es unknown
- 2017-05-18 AU AU2017265839A patent/AU2017265839B2/en active Active
- 2017-05-18 JP JP2018560460A patent/JP7071287B2/ja active Active
- 2017-05-18 DK DK17799675.8T patent/DK3459543T3/da active
- 2017-05-18 WO PCT/KR2017/005173 patent/WO2017200318A1/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| MX2018014080A (es) | 2019-04-04 |
| JP2019516707A (ja) | 2019-06-20 |
| KR102489052B1 (ko) | 2023-01-16 |
| KR20170131242A (ko) | 2017-11-29 |
| CN109475529B (zh) | 2022-02-22 |
| EP3459543A4 (en) | 2020-01-15 |
| RU2018144785A3 (enExample) | 2020-08-11 |
| RU2018144785A (ru) | 2020-06-19 |
| MX394245B (es) | 2025-03-19 |
| RU2753525C2 (ru) | 2021-08-17 |
| CN109475529A (zh) | 2019-03-15 |
| CA3024286A1 (en) | 2017-11-23 |
| EP3459543A1 (en) | 2019-03-27 |
| DK3459543T3 (da) | 2023-02-13 |
| BR112018073553A2 (pt) | 2019-03-19 |
| JP7071287B2 (ja) | 2022-05-18 |
| US10849882B2 (en) | 2020-12-01 |
| AU2017265839B2 (en) | 2022-10-27 |
| US20190298694A1 (en) | 2019-10-03 |
| EP3459543B1 (en) | 2022-12-21 |
| WO2017200318A1 (ko) | 2017-11-23 |
| AU2017265839A1 (en) | 2018-12-13 |
| ES2935596T3 (es) | 2023-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3459543T3 (pl) | Związek karbaminianowy do zapobiegania lub leczenia fibromialgii | |
| IL254393A0 (en) | Methods for treating diseases associated with pathological changes in protein | |
| PT3348557T (pt) | Imidazo[1,2a]piridinas para o tratamento ou prevenção de hiperuricemia ou gota | |
| GB201604027D0 (en) | Compounds | |
| SI3464336T1 (sl) | Spojine | |
| GB201709402D0 (en) | Compounds for treating t-pll | |
| GB201619694D0 (en) | Compounds | |
| IL258988A (en) | Methods for treating epilepsy | |
| HUE053402T2 (hu) | Kelátvegyületek | |
| GB201608777D0 (en) | Compounds | |
| IL256109A (en) | Methods for the treatment or prevention of protopathy | |
| GB201604022D0 (en) | Compounds | |
| ZA201906047B (en) | Compounds for treating tuberculosis | |
| AP2016009570A0 (en) | Triaminopyrimidine compounds useful for preventing or treating malaria | |
| GB201617103D0 (en) | Compound | |
| GB201609930D0 (en) | Interference mitigation | |
| IL263881B (en) | reducing interference | |
| GB201621520D0 (en) | Compounds | |
| GB201610497D0 (en) | Compound | |
| GB201622362D0 (en) | Compounds | |
| GB201601514D0 (en) | New processes and compounds | |
| GB201604031D0 (en) | Compounds | |
| GB201619526D0 (en) | Compound | |
| GB201619531D0 (en) | Compound | |
| GB201622072D0 (en) | Compounds |